Lido Advisors LLC Has $513,000 Holdings in CME Group Inc (CME)

Lido Advisors LLC boosted its holdings in shares of CME Group Inc (NASDAQ:CME) by 7.3% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 2,731 shares of the financial services provider’s stock after acquiring an additional 185 shares during the period. Lido Advisors LLC’s holdings in CME Group were worth $513,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Resources Investment Advisors Inc. grew its holdings in CME Group by 2,800.0% during the 4th quarter. Resources Investment Advisors Inc. now owns 145 shares of the financial services provider’s stock worth $27,000 after acquiring an additional 140 shares during the period. Ruggie Capital Group acquired a new stake in CME Group during the 4th quarter worth $28,000. Smith Asset Management Group LP grew its holdings in CME Group by 200.0% during the 4th quarter. Smith Asset Management Group LP now owns 150 shares of the financial services provider’s stock worth $28,000 after acquiring an additional 100 shares during the period. Nelson Roberts Investment Advisors LLC acquired a new stake in CME Group during the 4th quarter worth $33,000. Finally, Athena Capital Advisors LLC acquired a new stake in CME Group during the 4th quarter worth $43,000. 88.49% of the stock is owned by hedge funds and other institutional investors.

A number of analysts have commented on the stock. Citigroup set a $205.00 target price on shares of CME Group and gave the stock a “buy” rating in a report on Friday, February 15th. BidaskClub cut shares of CME Group from a “buy” rating to a “hold” rating in a research report on Thursday, January 31st. Keefe, Bruyette & Woods reissued a “hold” rating and set a $184.00 price target on shares of CME Group in a research report on Monday, December 10th. Atlantic Securities initiated coverage on shares of CME Group in a research report on Wednesday, November 28th. They set a “neutral” rating and a $200.00 price target on the stock. Finally, JPMorgan Chase & Co. initiated coverage on shares of CME Group in a research report on Friday, February 15th. They set an “underweight” rating and a $164.00 price target on the stock. Two analysts have rated the stock with a sell rating, eight have given a hold rating and seven have issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $194.00.

In related news, Director Jeffrey M. Bernacchi sold 10,087 shares of the business’s stock in a transaction on Tuesday, February 26th. The shares were sold at an average price of $177.94, for a total value of $1,794,880.78. Following the sale, the director now directly owns 42,004 shares of the company’s stock, valued at approximately $7,474,191.76. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO John W. Pietrowicz sold 17,960 shares of the business’s stock in a transaction on Wednesday, January 2nd. The shares were sold at an average price of $186.92, for a total transaction of $3,357,083.20. Following the completion of the sale, the chief financial officer now directly owns 44,780 shares in the company, valued at $8,370,277.60. The disclosure for this sale can be found here. Insiders sold a total of 32,609 shares of company stock worth $5,984,391 over the last ninety days. 0.43% of the stock is currently owned by insiders.

Shares of NASDAQ CME opened at $170.14 on Friday. The firm has a market cap of $60.88 billion, a PE ratio of 24.95, a PEG ratio of 2.15 and a beta of 0.31. CME Group Inc has a twelve month low of $153.90 and a twelve month high of $197.08. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 0.15.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Thursday, February 14th. The financial services provider reported $1.77 earnings per share for the quarter, topping analysts’ consensus estimates of $1.75 by $0.02. The company had revenue of $1.24 billion for the quarter, compared to analysts’ expectations of $1.22 billion. CME Group had a net margin of 45.53% and a return on equity of 9.85%. The business’s quarterly revenue was up 37.4% compared to the same quarter last year. During the same period last year, the firm posted $1.12 earnings per share. As a group, equities analysts anticipate that CME Group Inc will post 7.07 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 25th. Investors of record on Friday, March 8th will be given a $0.75 dividend. This is a boost from CME Group’s previous quarterly dividend of $0.70. This represents a $3.00 annualized dividend and a yield of 1.76%. The ex-dividend date of this dividend is Thursday, March 7th. CME Group’s payout ratio is currently 43.99%.

COPYRIGHT VIOLATION WARNING: “Lido Advisors LLC Has $513,000 Holdings in CME Group Inc (CME)” was first published by Modern Readers and is owned by of Modern Readers. If you are reading this story on another site, it was stolen and reposted in violation of U.S. & international copyright and trademark law. The legal version of this story can be viewed at https://www.modernreaders.com/news/2019/03/17/lido-advisors-llc-has-513000-holdings-in-cme-group-inc-cme.html.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

See Also: Strike Price

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.